Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - filgrastim, quantity: 960 microgram/ml - injection, solution - excipient ingredients: sorbitol; polysorbate 80; sodium hydroxide; glutamic acid; water for injections - indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs in doses not usually requiring bone marrow transplantation. ,indicated for reducing the duration of neutropenia and clinical sequelae in patients undergoing induction and consolidation chemotherapy for acute myeloid leukaemia. ,indicated for the mobilisation of autologous peripheral blood progenitor cells alone, or following myelosuppressive chemotherapy, in order to accelerate neutrophil and platelet recovery by infusion of such cells after myeloablative or myelosuppressive therapy in patients with non-myeloid malignancies. ,indicated for the mobilisation of peripheral blood progenitor cells, in normal volunteers, for use in allogeneic peripheral blood progenitor cell transplantation.,in patients receiving myeloablative chemotherapy, is indicated for reducing the duration of neutropenia and clinical sequelae following autologous or allogeneic bone marrow transplantation.,indicated for chronic administration to increase neutrophil counts and to reduce the incidence and duration of infections in patients with severe chronic neutropenia.,indicated in patients with hiv infection, for reversal of clinically significant neutropenia and subsequent maintenance of adequate neutrophil counts during treatment with antiviral and/or other myelosuppressive medications.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

cmasd pty ltd - guazatine acetates - aqueous concentrate - guazatine acetates guanidine active 400.0 g/l - fungicide - citrus | rockmelon or cantaloup | tomato | cantaloupe | canteloup | grapefruit | lemon | lime | mandarin | musk melon | orange - alternaria rot | blue mould on citrus - p. italicum | green mould | grey mould - botrytis cinerea | sour or yeasty rot | stem end rots | botrytis blight | botrytis rot | bunch rot

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

farmalinx pty ltd - sulfur (s) as wettable sulfur - dry flowable - sulfur (s) as wettable sulfur mineral-sulfur active 800.0 g/kg - miticide - citrus | grape - table | grapevine | kiwi fruit | mangosteen | ornamental | pome fruit | rambutan | stone fruit (see label for e - bean or broad bean rust- u. viciae-fabae | bean spider mite | black spot - venturia spp. | brown citrus rust mite | brown rot - monilinia spp. | carmine mite | citrus bud mite | citrus melanose | citrus rust mite or maori mite | grapeleaf blister mite | lichen | mite | moss | powdery mildew | powdery mildew on grapevine | powdery mildew on pome | rust - uromyces spp. | stone fruit rust | tomato russet mite | vine mite | white louse scale | black spot (scab) | blossom blight | brown citrus mite | citrus rust mites | citrus snow scale | red spider mite | rust mite | spider mite | tomato mite (47236) | transzchelia pruni-spinosae | two-spotted mite | two-spotted spider mite | uromyces phaseoli var. typica | vineleaf blister mite

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kenso corporation (m) sdn. bhd. - sulphur(s) present as elemental sulphur - water dispersible granule - sulphur(s) present as elemental sulphur mineral-sulphur active 800.0 g/kg - mixed function pesticide - citrus | grape | grape - wine | kiwi fruit | mangosteen | nectarine | ornamental crops | peach | plum | pome fruit | rambutan | - bean spider mite | black spot - colletotrichum acutatum | blossom blight - monilinia laxa | brown citrus rust mite | brown rot | bud mite | carmine mite | citrus melanose | citrus rust mite or maori mite | grapeleaf blister mite | lichen | mite | moss | powdery mildew | powdery mildew - oidium spp. | rust | rust - uromyces appendiculatus | tomato russet mite | vine mite | white louse scale | anthracnose | bean rust | brown citrus mite | brown rot | citrus rust mites | citrus snow scale | red spider mite | rust mite | spider mite | tomato mite (47236) | two-spotted mite | two-spotted spider mite | vineleaf blister mite

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

upl australia pty ltd - sulfur; sulfur - water dispersible granule - sulfur mineral-sulfur active 800.0 g /kg; sulfur mineral-sulfur active 800.0 g/kg - fungicide - citrus | grape - table | grape - wine | grapevine | kiwi fruit | mangosteen | ornamental | pome fruit | rambutan | stone fruit ( - bean or broad bean rust- u. viciae-fabae | bean spider mite | black spot - venturia spp. | brown citrus rust mite | brown fruit rot - monilinia fructicola | bud mite | citrus bud mite | citrus melanose | citrus rust mite or maori mite | grapeleaf blister mite | mite | powdery mildew | powdery mildew - podosphaera leucotricha | powdery mildew - sphaerotheca spp. | powdery mildew on grapevine | powdery mildew on strawberry | prune rust | rust - uromyces spp. | rust mite | tomato russet mite | two spotted mite | vine mite | white louse scale | black spot (scab) | blossom blight | brown citrus mite | brown rot | citrus rust mites | citrus snow scale | red spider mite | rust mite | sphaerotheca macularis | spider mite | tomato mite (47236) | two-spotted mite | two-spotted spider mite | uromyces phaseoli var. typica | vineleaf blister mite

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - sulfur (s) as wettable sulfur - wettable powder - sulfur (s) as wettable sulfur mineral-sulfur active 800.0 g/kg - fungicide - citrus fruit or tree | grape | ornamental | pome fruit | stone fruit (see label for exceptions) | vegetable (see label for excep - bean spider mite | black spot | brown citrus rust mite | brown rot - monilinia spp. | carmine mite | citrus bud mite | citrus rust mite or maori mite | grapeleaf blister mite | powdery mildew | powdery mildew on grapevine | powdery mildew on pome | rust | stone fruit rust | tomato russet mite | vine mite | white louse scale | blossom blight | brown citrus mite | citrus rust mites | citrus snow scale | red spider mite | rust mite | scab | spider mite | tomato mite (47236) | transzchelia pruni-spinosae | two-spotted mite | two-spotted spider mite | vineleaf blister mite

Israel - English - Ministry of Health

abic marketing ltd, israel - methotrexate - solution for injection - methotrexate 25 mg/ml - methotrexate - methotrexate - antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. palliation of acute lymphocytic leukemia. abitrexate is also indicated in the treatment and prophylaxis of meningeal leukemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. in combination with other anticancer agents, abitrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. abitrexate is effective in the treatment of the advanced stages (iii and iv peter's staging system) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. psoriasis: because of the high risk attending its use, abitrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. rheumatoid arthritis: abitrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose nsaids and usually a trial of at least one or more disease-modifying antirheumatic drugs.

Israel - English - Ministry of Health

abic marketing ltd, israel - fluorouracil - solution for injection - fluorouracil 50 mg/ml - fluorouracil - fluorouracil - palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas, in selected patients considered incurable by surgery or other means.as leucovorin-fluorouracil chemotherapy combination for cancer treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - filgrastim, quantity: 300 microgram - injection, solution - excipient ingredients: acetate; water for injections; polysorbate 80; sorbitol; sodium - a) to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs in doses not usually requiring bone marrow transplantation, b) for reducing the duration of neutropenia and clinical sequelae in patients undergoing induction and consolidation chemotherapy for acute myeloid leukaemia, c) for the mobilisation of autologous peripheral blood progenitor cells alone, or following myelosuppressive chemotherapy, in order to accelerate neutrophil and platelet recovery by infusion of such cells after myeloablative or myelosuppressive therapy in patients with non-myeloid malignancies, d) for the mobilisation of peripheral blood progenitor cells, in normal volunteers, for use in allogeneic peripheral blood progenitor cell transplantation, e) in patients receiving myeloablative chemotherapy, for reducing the duration of neutropenia and clinical sequelae following autologous or allogeneic bone marrow transplantation, f) for chronic administration to increase neutrophil counts and to reduce the incidence and duration of infections in patients with severe chronic neutropenia, g) in patients with hiv infection, for reversal of clinically significant neutropenia and subsequent maintenance of adequate neutrophil counts during treatment with antiviral and/or other myelosuppressive medications.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - filgrastim, quantity: 480 microgram - injection, solution - excipient ingredients: polysorbate 80; sodium; water for injections; acetate; sorbitol - a) to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs in doses not usually requiring bone marrow transplantation, b) for reducing the duration of neutropenia and clinical sequelae in patients undergoing induction and consolidation chemotherapy for acute myeloid leukaemia, c) for the mobilisation of autologous peripheral blood progenitor cells alone, or following myelosuppressive chemotherapy, in order to accelerate neutrophil and platelet recovery by infusion of such cells after myeloablative or myelosuppressive therapy in patients with non-myeloid malignancies, d) for the mobilisation of peripheral blood progenitor cells, in normal volunteers, for use in allogeneic peripheral blood progenitor cell transplantation, e) in patients receiving myeloablative chemotherapy, for reducing the duration of neutropenia and clinical sequelae following autologous or allogeneic bone marrow transplantation, f) for chronic administration to increase neutrophil counts and to reduce the incidence and duration of infections in patients with severe chronic neutropenia, g) in patients with hiv infection, for reversal of clinically significant neutropenia and subsequent maintenance of adequate neutrophil counts during treatment with antiviral and/or other myelosuppressive medications.